Deep Medicine Acquisition Corp. Rights
DMAQR
DMAQR was delisted on the 31st of January, 2024.
29 hedge funds and large institutions have $576K invested in Deep Medicine Acquisition Corp. Rights in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
48% more capital invested
Capital invested by funds: $388K → $576K (+$188K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
3% less funds holding
Funds holding: 30 → 29 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$3.17K |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$1K |
| 3 |
CAC
Cowen and Company
New York
|
+$830 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$7.15K |
| 2 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$6.85K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$57 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
26
HRT Financial
New York
| $2K | – | – | – |
|
|
BCM
27
Bluefin Capital Management
New York
| $749 | – | – | – |
|
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1K | -16,749 | Closed |
|
DMAQR Hedge Fund Activity: Q4 2022 in Review
29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q4 2022, worth a combined $576K — up 48% from $388K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DMAQR and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was Meteora Capital, adding an estimated $3.17K. The largest seller was Hudson Bay Capital Management, cutting an estimated $7.15K.
- 29 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q4 2022, down from 30 in Q3 2022.
- Funds reported $576K of Deep Medicine Acquisition Corp. Rights stock for Q4 2022, up 48% quarter-over-quarter.
- 1 fund opened new Deep Medicine Acquisition Corp. Rights positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Deep Medicine Acquisition Corp. Rights buyer in Q4 2022 was Meteora Capital, an estimated $3.17K added.
- The largest Deep Medicine Acquisition Corp. Rights seller in Q4 2022 was Hudson Bay Capital Management, an estimated $7.15K sold.
Based on aggregated 13F filings for Q4 2022.